Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Konger RL et al. Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. 2008 Prostaglandins Other Lipid Mediat. pmid:18555720
Detopoulou P et al. PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics. 2012 Prostaglandins Other Lipid Mediat. pmid:22079887
Martínez L et al. Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. 1999 Prostaglandins Other Lipid Mediat. pmid:10367296
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Tiemann U et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. 2001 Prostaglandins Other Lipid Mediat. pmid:11403499
Travers JB et al. Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. 1998 Prostaglandins Other Lipid Mediat. pmid:9990675
Balestrieri ML et al. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity and arachidonate release by ATP in endothelial cells. 1998 Prostaglandins Other Lipid Mediat. pmid:9990678
Kudolo GB and DeFronzo RA Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. 1999 Prostaglandins Other Lipid Mediat. pmid:10410380
Martin-Chouly CA et al. Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. 2000 Prostaglandins Other Lipid Mediat. pmid:10751643
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Sakellariou M et al. Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB x NZW F1 hybrid mice. 2008 Prostaglandins Other Lipid Mediat. pmid:18248752
Chen C and Bazan NG Lipid signaling: sleep, synaptic plasticity, and neuroprotection. 2005 Prostaglandins Other Lipid Mediat. pmid:16099392
Itadani K et al. Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands. 1998 Prostaglandins Other Lipid Mediat. pmid:9653774
Arai H Platelet-activating factor acetylhydrolase. 2002 Prostaglandins Other Lipid Mediat. pmid:12432911
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Hla T Prostaglandins & other lipid mediators: a new phase, a new team. 2004 Prostaglandins Other Lipid Mediat. pmid:15165026
Ruan Z et al. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. 2004 Prostaglandins Other Lipid Mediat. pmid:15165033
Nomikos TN et al. Application of a TCA-precipitation method for the determination of 1-alkyl-sn-glycero-3-phosphate: Acetyl-CoA acetyltransferase in human renal tissue. 2004 Prostaglandins Other Lipid Mediat. pmid:15165037
Watanabe S et al. Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11534547
Beck-Speier I et al. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2. 2003 Prostaglandins Other Lipid Mediat. pmid:14518563
Ishiura Y et al. In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. 2005 Prostaglandins Other Lipid Mediat. pmid:15789611
Gaudreault E et al. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. 2005 Prostaglandins Other Lipid Mediat. pmid:15789613
Calcerrada MC et al. Selective translocation of protein kinase c isozymes by PAF in rabbit platelets. 2005 Prostaglandins Other Lipid Mediat. pmid:15789614
Shibata K et al. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. 2000 Prostaglandins Other Lipid Mediat. pmid:11060901
Hiran T et al. Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. 2001 Prostaglandins Other Lipid Mediat. pmid:11785782
Cui S et al. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver. 2006 Prostaglandins Other Lipid Mediat. pmid:16846785
Menezes-de-Lima O et al. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. 2006 Prostaglandins Other Lipid Mediat. pmid:16939877
Vlachogianni IC et al. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions. 2015 Prostaglandins Other Lipid Mediat. pmid:26358846
Besana A et al. Lipids and two-pore domain K+ channels in excitable cells. 2005 Prostaglandins Other Lipid Mediat. pmid:16099395
Shibamoto T et al. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers. 2005 Prostaglandins Other Lipid Mediat. pmid:16303618
Ho YS et al. Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase. 1999 Protein Eng. pmid:10469831
Chérifi F et al. Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor. 2014 Protein J. pmid:24384926
Fonseca FV et al. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. 2006 Protein J. pmid:16729248
Aquino EN et al. Proteomic Analysis of Neutrophil Priming by PAF. 2016 Protein Pept. Lett. pmid:26631175
Gui C et al. Understanding the regulation mechanisms of PAF receptor by agonists and antagonists: molecular modeling and molecular dynamics simulation studies. 2007 Proteins pmid:17243151
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Kuśnierz B and Naskalski JW [Mediators of the inflammatory response in the course of acute pancreatitis]. 1999 Prz. Lek. pmid:10575924
Myśliwiec M and Myśliwiec B [Blood platelets, prostaglandin and complement interactions in inflammation]. 1982 Prz. Lek. pmid:6753039
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Touvay C et al. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. 1991 Pulm Pharmacol pmid:1804494
Salari H and Schellenberg RR Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle. 1991 Pulm Pharmacol pmid:1804490
Macquin-Mavier I et al. Effects of platelet-activating factor on lung epithelial permeability in the guinea-pig. 1991 Pulm Pharmacol pmid:1806136
Underwood SL et al. RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo. 1992 Pulm Pharmacol pmid:1280178
Lai CK and Holgate ST Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle. 1992 Pulm Pharmacol pmid:1591466
Spina D et al. The role of platelet activating factor in allergic inflammation. 1989 Pulm Pharmacol pmid:2520484
Björck T and Dahlén SE Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. 1993 Pulm Pharmacol pmid:8477156
Templeton AG et al. Effects of S-salbutamol on human isolated bronchus. 1998 Pulm Pharmacol Ther pmid:9802957
Webber SE et al. PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition. 1997 Pulm Pharmacol Ther pmid:9514626
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Barnes PJ The changing face of asthma. 1987 Q. J. Med. pmid:3310071